Schrodinger, Inc.
SDGR Healthcare Health Information Services
Schrodinger, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $255.9 million, up 23.3% from fiscal 2024.
- Revenue
- +18.7%
- EPS
- −11.1%
- Free cash flow
- +21.6%
Quarter to September 2026, against a year earlier
Follow SDGR
Alert me
Schrodinger, Inc. (SDGR) P/S ratio
As of 5 November 2026, Schrodinger, Inc. (SDGR) trades at a P/S ratio of 8.1×. Over the past ten years it has ranged from 1.9× (February 2020) to 62.8× (March 2021); the current reading is higher than 35% of that period. That is above the Health Information Services industry median of 1.8× and above the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 5.1× | (24.02%) |
| FY2024 | 6.8× | (41.96%) |
| FY2023 | 11.6× | 61.60% |
| FY2022 | 7.2× | (59.60%) |
| FY2021 | 17.8× | (59.46%) |
| FY2020 | 44.0× | 2,086.94% |
| FY2019 | 2.0× | 0.00% |
| FY2018 | 2.0× | 0.00% |
| FY2017 | 2.0× | — |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 8.6× | 84.23% |
| Jun 2026 | 4.7× | 42.14% |
| Mar 2026 | 3.3× | (35.75%) |
| Dec 2025 | 5.1× | (10.70%) |
| 27 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| TDOC Teladoc Health, Inc. compare | 0.7× |
| PRVA Privia Health Group, Inc. compare | 1.2× |
| OMCL Omnicell, Inc. compare | 1.4× |
| GDRX GoodRx Holdings, Inc. compare | 1.5× |
| HSTM HealthStream, Inc. compare | 2.7× |
| OMDA Omada Health, Inc. compare | 3.6× |
| CERT Certara, Inc. compare | 4.7× |
| SDGR Schrodinger, Inc. | 8.1× |
| HTFL Heartflow, Inc. compare | 21.3× |
| Health Information Services industry median | 1.8× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on SDGR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement